Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Adenosquamous Carcinoma of the Pancreas”

13 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 13 of 13 results

Testing effectiveness (Phase 2)Study completedNCT02022033
What this trial is testing

BrUOG 295: Adjuvant FOLFOX-A For Resected Pancreatic Cancer: A Phase II Brown University Oncology Research Group Trial

Who this might be right for
Pancreatic Cancer
Brown University 25
Early research (Phase 1)Looking for participantsNCT04157127
What this trial is testing

Th-1 Dendritic Cell Immunotherapy Plus Standard Chemotherapy for Pancreatic Adenocarcinoma

Who this might be right for
Pancreatic AdenocarcinomaPancreatic CancerPancreatic Adenosquamous Carcinoma
Diakonos Oncology Corporation 18
Testing effectiveness (Phase 2)WithdrawnNCT05216120
What this trial is testing

Pemigatinib in Subjects With Adenosquamous Carcinoma of the Pancreas

Who this might be right for
Pancreas Cancer
HonorHealth Research Institute
Testing effectiveness (Phase 2)Looking for participantsNCT04858334
What this trial is testing

APOLLO: A Randomized Phase II Double-Blind Study of Olaparib Versus Placebo Following Curative Intent Therapy in Patients With Resected Pancreatic Cancer and a Pathogenic BRCA1, BRCA2 or PALB2 Mutation

Who this might be right for
Pancreatic Acinar Cell CarcinomaPancreatic Adenosquamous CarcinomaPancreatic Squamous Cell Carcinoma+4 more
National Cancer Institute (NCI) 152
Not applicableStudy completedNCT05292859
What this trial is testing

Long-Term Follow-up Study of Subjects Treated With Autologous T Cells Using the Sleeping Beauty System to Express TCRs

Who this might be right for
Gynecologic CancerColorectal CancerPancreatic Cancer+7 more
Alaunos Therapeutics 7
Large-scale testing (Phase 3)Active Not RecruitingNCT04340141
What this trial is testing

Testing the Use of the Usual Chemotherapy Before and After Surgery for Removable Pancreatic Cancer

Who this might be right for
Pancreatic Adenosquamous CarcinomaResectable Pancreatic AdenocarcinomaPancreatic Cancer
Alliance for Clinical Trials in Oncology 358
Large-scale testing (Phase 3)Active Not RecruitingNCT06115499
What this trial is testing

The PLATINUM Trial: Optimizing Chemotherapy for the Second-Line Treatment of Metastatic BRCA1/2 or PALB2-Associated Metastatic Pancreatic Cancer

Who this might be right for
Pancreatic Acinar Cell CarcinomaPancreatic AdenocarcinomaPancreatic Adenosquamous Carcinoma+4 more
Alliance for Clinical Trials in Oncology 10
Testing effectiveness (Phase 2)Study completedNCT04116073
What this trial is testing

INCMGA00012 in Patients With Previously Treated Unresectable or Metastatic Adenosquamous Pancreatic or Ampullary Cancer

Who this might be right for
Pancreatic Cancer Non-resectablePancreatic Cancer Metastatic
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 25
Testing effectiveness (Phase 2)Study completedNCT04896073
What this trial is testing

Superenhancer Inhibitor Minnelide in Advanced Refractory Adenosquamous Carcinoma of the Pancreas (ASCP)

Who this might be right for
Adenosquamous Carcinoma of the Pancreas
National Cancer Institute (NCI) 16
Testing effectiveness (Phase 2)Looking for participantsNCT05988918
What this trial is testing

Multicenter Trial of ESK981 in Patients With Select Solid Tumors

Who this might be right for
Pancreatic AdenocarcinomaAdenosquamous CarcinomaPancreatic Neuroendocrine Tumor+4 more
University of Michigan Rogel Cancer Center 66
Testing effectiveness (Phase 2)Temporarily pausedNCT05419479
What this trial is testing

Switch Maintenance in Pancreatic

Who this might be right for
Pancreatic CancerAdenocarcinoma of the PancreasSquamous Cell Carcinoma of Pancreas+1 more
James Cleary, MD, PhD 46
Large-scale testing (Phase 3)Looking for participantsNCT07491445
What this trial is testing

Study of Daraxonrasib and Daraxonrasib + GnP as First-line Treatment in Patients With Metastatic Pancreatic Adenocarcinoma

Who this might be right for
Pancreatic CancerPancreatic Cancer MetastaticPDAC+5 more
Revolution Medicines, Inc. 900
Testing effectiveness (Phase 2)Ended earlyNCT05194735
What this trial is testing

Phase I/II Study of Autologous T Cells to Express T-Cell Receptors (TCRs) in Subjects With Solid Tumors

Who this might be right for
Gynecologic CancerColorectal CancerPancreatic Cancer+9 more
Alaunos Therapeutics 8